Morgan Stanley Maintains Equal-Weight on 10x Genomics, Raises Price Target to $70

Benzinga · 1d ago
Morgan Stanley analyst Tejas Savant maintains 10x Genomics (NASDAQ:TXG) with a Equal-Weight and raises the price target from $40 to $70.